{
    "nctId": "NCT05734950",
    "briefTitle": "Biological Characteristics of Older Women (> 70 Years) With ER Positive, HER2 Negative Early Breast Cancer",
    "officialTitle": "Biological Characteristics of Older Women (> 70 Years) With Oestrogen-receptor (ER) Positive, Human Epidermal Growth Factor 2 (HER2) Negative Early Breast Cancer: Definition of Molecular and Genomic Features.",
    "overallStatus": "ENROLLING_BY_INVITATION",
    "conditions": "Breast Cancer Female",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Distribution of TILs percentage",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Post-menopausal women aged \\>70 years at the time of diagnosis of invasive breast cancer.\n* ER positive (Allred score \\>5/8), HER2 negative early invasive BC.\n* Stage I-III BC.\n* Surgical tissue available.\n* No pre-surgical systemic therapy (i.e., no pre-operative ET or chemotherapy).\n* Planned adjuvant ET with an aromatase-inhibitor.\n* No adjuvant chemotherapy.\n* Surgery was performed between 1st January 2014 and 31st December 2016.\n\nExclusion Criteria:\n\n* Pre- or perimenopausal.\n* ER negative or HER2-positive BC.\n* Multifocal cancer where not all of foci ER positive HER2 negative\n* Bilateral breast cancer.\n* Stage IV breast cancer.\n* Benign histology or DCIS.\n* Pre-surgical treatment.\n* Prior chemotherapy for BC.",
    "sex": "FEMALE",
    "minimumAge": "71 Years",
    "stdAges": "OLDER_ADULT"
}